줄기세포치료제 시장은 2022년 22억 7,849만 달러에서 2028년 62억 689만 달러로 성장할 것으로 예상된다. 2022년부터 2028년까지 연평균 성장률(CAGR) 18.2%로 성장할 것으로 추정됩니다.
줄기 세포는 특수한 기능을 가진 다른 모든 세포가 생성되는 예비 신체 세포입니다. 신체나 임상 실험실의 통제된 환경에서 이러한 세포는 분열하여 딸세포라고 불리는 더 많은 세포를 형성합니다. 현대 보건과학의 도래와 함께 이들 세포는 질병의 발생을 이해하고, 첨단재생의학의 탄생과 기타 약물의 발견에 중요한 역할을 한다는 사실이 입증되었습니다. 줄기 세포는 무엇보다도 배아, 골수, 체지방, 제대혈에서 형성됩니다.
전략적 통찰력
시장 통찰력
유기 및 무기 증가 주요 업체별 전략
주요 시장 업체들은 시장에서 경쟁력을 유지하기 위해 인수합병, 확장, 신제품 출시 등 다양한 유기 및 무기 전략을 취하고 있습니다.
- 2022년 10월 메디포스트(대표 오원일)가 세포치료제 및 유전자치료제 CDMO(수탁개발제조) 사업을 국내에 개시한다고 발표했다. 회사는 새로운 GMP 시설에 CDMO 전용 최신 장비를 갖춘 10개의 클린룸과 생산 시설을 수용할 것이라고 발표했습니다.
- 2019년 12월 Lineage Cell Therapeutics와 AgeX Therapeutics는 파트너십을 맺고 미국에 유도 만능 줄기 세포 생성 방법에 대한 특허를 취득했습니다.
- 2021년 6월 Allogene Therapeutics, Inc.는 미국 식품의약국(FDA)이 ALLO-605에 패스트 트랙 지정을 부여했다고 발표했습니다. 재발성 또는 불응성 다발성 골수종 치료를 위해 BCMA를 표적으로 하는 차세대 AlloCAR T 치료법. FDA는 다른 표준 다발성 골수종 치료법에 실패한 환자의 충족되지 않은 요구를 해결하기 위해 ALLO-605의 잠재력을 기반으로 패스트 트랙 지정을 승인했습니다.
따라서 FDA에서는 많은 유기 및 무기 전략을 사용하고 있습니다. 줄기 세포 치료 시장은 의료 전문가가 향상된 서비스를 제공할 수 있도록 해줍니다.
줄기 세포 치료 시장의 수익성 있는 지역
줄기 세포 치료는 전 세계적으로 널리 조사되었습니다. 줄기세포는 주로 죽어가는 세포를 대체하고 손상된 조직을 재구성하는 데 사용됩니다. 지금까지 수행된 광범위한 줄기 세포 연구 결과를 바탕으로 많은 과학자들은 이러한 세포가 암 및 심혈관 질환과 같은 질병의 치료법을 생성하는 데 활용될 수 있다고 주장해 왔습니다. 새로 개발된 줄기세포 치료법에는 질병을 일으키는 세포를 줄기세포로 대체하는 것이 포함됩니다. 줄기 세포와 관련된 많은 잠재적 치료법은 다양한 임상 시험 단계에 있습니다. FDA는 또한 줄기세포 이식과 관련된 합병증 치료와 관련된 몇 가지 줄기세포 치료법을 승인했습니다. 2021년 9월 미국 식품의약국(FDA)은 12세 이상 환자의 '이식편대숙주병'(GVHD) 치료용으로 '룩소리티닙'을 승인했다고 발표했습니다. 룩소리티닙은 줄기세포 이식과 관련된 치명적인 합병증으로 고통받는 환자에게 새로운 희망을 제공합니다.
연구원들은 자가면역 질환 치료에 줄기세포 치료법을 사용하는 방법을 추가로 조사하고 있습니다. 예를 들어, 줄기세포는 손상된 장기의 세포로 변할 수 있으며 자가면역질환 치료에 사용됩니다. 치료는 중간엽줄기세포나 태아줄기세포를 이용하여 진행됩니다. 조혈줄기세포는 현재 면역체계 질환; 혈액 장애; 신경 장애; 대사 장애; 유전 질환; 및 백혈병, 림프종과 같은 암 유형.
유형 통찰력
줄기세포 치료 시장은 유형에 따라 성체줄기세포치료제, 유도만능줄기세포치료제, 배아줄기세포치료제로 분류됩니다. 세포치료제, 기타 줄기세포치료제. 성체 줄기세포 치료 부문은 2021년 가장 큰 시장 점유율을 차지했습니다. 그러나 유도 만능 줄기세포 치료 부문은 예측 기간(2022~2028년) 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.
치료 인사이트< /h3>
전 세계 줄기세포치료제 시장은 치료에 따라 동종이계와 자가치료로 양분된다. 동종이형 부문은 2021년에 더 큰 줄기 세포 치료 시장 점유율을 차지했습니다. 더욱이, 자가 유래 부문은 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.
Application Insights
측면에서 응용 분야에 따라 줄기 세포 치료 시장은 근골격계, 피부과, 심장학, 약물 발견 및 개발, 기타 응용 분야로 구분됩니다. 약물 발견 및 개발 부문은 2021년 가장 큰 시장 점유율을 차지했으며 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.
유형별 줄기세포 치료 시장 – 2021년 및 2028년
최종 사용자 통찰력
최종 사용자를 기준으로 줄기 세포 치료 시장은 학문 분야로 양분됩니다. & 연구소 및 병원 & 진료소. 학문적 & 연구 기관 부문은 2021년에 더 큰 시장 점유율을 차지했으며, 동일한 부문은 예측 기간(2022~2028년) 동안 시장에서 더 높은 CAGR을 기록할 것으로 예상됩니다.
줄기 세포 치료 시장의 기업 인수합병 등 무기적 전략을 주로 채택한다. 최근 시장의 몇 가지 주요 개발 사항은 다음과 같습니다.
- 2021년 6월, USFDA는 차세대 ALLO-605에 패스트 트랙 지정을 부여했습니다. 재발성 또는 불응성 다발성 골수종 치료를 위해 BCMA를 표적으로 하는 Allogene Therapeutics, Inc.가 제공하는 AlloCAR T 치료법. 이번 지정은 다른 표준 다발성 골수종 치료법에 반응하지 않는 환자의 충족되지 않은 요구를 해결하기 위한 ALLO-605의 잠재력을 토대로 부여되었습니다.
- 2021년 6월, MEDIPOST는 다음과 같이 발표했습니다. 회사는 무릎 골관절염 줄기세포 제품인 CARTISTEM과 SMUP-IA-01의 생산 시설을 확장했으며 GMP(우수제조관리기준) 인증 준비에 착수할 예정입니다.
- 2022년 9월 Caladrius Biosciences , Inc.와 Cend Therapeutics, Inc.는 두 회사의 합병 제안이 Caladrius의 승인에 따라 종료되었다고 발표했습니다. 합병된 회사는 Lisata Therapeutics, Inc.로 운영되며 주로 Caladrius’ 외에도 다양한 종양 적응증에서 CendR 플랫폼 기술 제품 후보를 발전시키는 데 중점을 둘 것입니다. 기존 개발 프로그램을 사용합니다.
- 2019년 3월에 BioTime, Inc는 줄기 세포 치료 제품 포트폴리오를 통합하기 위해 재생 의학을 다루는 Asterias Biotherapeutics, Inc.를 인수했습니다.
회사 프로필
- MEDIPOST
- Pharmicell Co., Inc.
- RichSource
- BioTime, Inc.
- Mesoblast Limited
- Holostem Terapie Avanzate Srl
- US Stem Cell, Inc.
- Caladrius Biosciences, Inc.
- TiGenix NV
- 알로소스
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Stem cells are preliminary body cells from which all other cells with specialized functions are generated. Under controlled environment in the body or a clinical laboratory, these cells divide to form more cells called daughter cells. Due to the advent of modern health science, these cells play a major role in understanding the occurrence of diseases, generation of advanced regenerative medicines, and drug discovery. There are certain sources such as embryo, bone marrow, body fats, and umbilical cord blood amongst others, where stem cells are generated.
Increasing research activities related to stem cell therapy for effective disease management and growing prevalence of cancer are the most significant factors responsible for the overall market growth.
Based on type segment, the adult stem cell therapy segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
Based on the treatment, allogenic segment took the forefront leaders in the worldwide market by accounting largest share in 2021.
Academic & Research institutes segment dominated the global stem cell therapy market and accounted for the largest market share during the forecast period of 2022-2028.
MEDIPOST, RichSource, BioTime, Inc., Mesoblast Limited, Holostem Terapie Avanzate Srl, U.S. Stem Cell, Inc., TiGenix NV, AlloSource, NuVasive Inc, JCR Pharmaceuticals Co. Ltd. and among others are among the leading companies operating in the stem cell therapy market.
Global stem cell therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
The List of Companies - Stem Cell Therapy Market
- MEDIPOST
- RichSource
- BioTime, Inc.
- Mesoblast Limited
- Holostem Terapie Avanzate Srl
- U.S. Stem Cell, Inc.
- TiGenix NV
- AlloSource
- NuVasive Inc
- JCR Pharmaceuticals Co. Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2023
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2023
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2023
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2023
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2023
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2023
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)